X hits on this document

Powerpoint document

Considerations for Exposure to Diazinon and Chlorpyrifos - page 47 / 49

132 views

0 shares

0 downloads

0 comments

47 / 49

References from our laboratory, continued

Furlong, C.E., T.B. Cole, G.P. Jarvik, L.G. Costa. 2002. Pharmacogenomic considerations of the paraoxonase polymorphisms. Pharmacogenomics 3(3):341-8.

Jarvik GP, Tsai NT, McKinstry LA Wani R, Brophy VH, Richter RJ., Schellenberg GD, Heagerty PJ, Hatsukami TS, Furlong CE. 2002. Vitamin C and E intake are associated with increased PON1 activity. Atheroscler. Thromb. Vasc. Biol. 22(8):1329-33.

Jarvik GP, R Jampsa, RJ Richter, C Carlson, M Rieder, D Nickerson and CE Furlong. 2003. Novel Paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 status. Pharmacogenetics 13:291-295.

Jarvik GP, Hatsukami TS, Carlson CS, Richter RJ, Jampsa R, Brophy VH, Margolin S, Rieder MJ, Nickerson DA, Schellenberg GD, Heagerty PJ, Furlong CE. 2003. Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease.  Arterioscler Thromb Vasc Biol 23:1465-1471.

Cole TB, RL Jampsa, BJ Walter, TL Arndt, RJ Richter, DM Shih, A Tward, AJ Lusis, RM Jack, LG Costa, and CE Furlong. 2003. Expression of human paraoxonase (PON1) during development. Pharmacogenetics 13:357-364.

Kelada SN, P Costa-Mallen, H Checkoway, CE Furlong, GP. Jarvik, HA Viernes, FM Farin, T Smith-Weller, GM. Franklin, WT Longstreth Jr., PD. Swanson, and LG Costa. 2003.  Paraoxonase 1 promoter and coding region polymorphisms in Parkinson’s disease. J Neurol Neurosurg Psychiatry 74:546-547.  

B. Eskenazi, K. Harley, A. Bradman, E. Weltzien, N. Jewell, D. Barr, C. Furlong, and N. Holland.  2004.  Association of in utero Organophosphate Pesticide Exposure and Fetal Growth and Length of Gestation in an Agricultural Populations. Environ Health Perspect 112:1116-1124

RJ Richer, RL Jampsa, GP Jarvik, LG Costa and CE Furlong.  Determination of paraoxonase 1 (PON1) status and genotypes at specific polymorphic sites. Current Protocols in Toxicology, MD Mains, LG Costa, DJ Reed, E Hodgson, eds.  John Wiley and Sons, NY, NY.  2004: 4.12.1-4.12.19.

Rozek LS, Hatsukami TS,. Richter RJ, Ranchalis J, Nakayama K, McKinstry LA, Gortner DA, Boyko, E, Schellenberg GD, Furlong CE, Jarvik GP. 2005. The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status. J Lipid Res 46:1888-1895.

Furlong, C.E., T.B. Cole, G.P. Jarvik, L.G. Costa. 2002. Pharmacogenomic considerations of the paraoxonase polymorphisms. Pharmacogenomics 3(3):341-8.

Jarvik GP, Tsai NT, McKinstry LA Wani R, Brophy VH, Richter RJ., Schellenberg GD, Heagerty PJ, Hatsukami TS, Furlong CE. 2002. Vitamin C and E intake are associated with increased PON1 activity. Atheroscler. Thromb. Vasc. Biol. 22(8):1329-33.

Jarvik GP, R Jampsa, RJ Richter, C Carlson, M Rieder, D Nickerson and CE Furlong. 2003. Novel Paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 status. Pharmacogenetics 13:291-295.

Jarvik GP, Hatsukami TS, Carlson CS, Richter RJ, Jampsa R, Brophy VH, Margolin S, Rieder MJ, Nickerson DA, Schellenberg GD, Heagerty PJ, Furlong CE. 2003. Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease.  Arterioscler Thromb Vasc Biol 23:1465-1471.

Cole TB, RL Jampsa, BJ Walter, TL Arndt, RJ Richter, DM Shih, A Tward, AJ Lusis, RM Jack, LG Costa, and CE Furlong. 2003. Expression of human paraoxonase (PON1) during development. Pharmacogenetics 13:357-364.

Kelada SN, P Costa-Mallen, H Checkoway, CE Furlong, GP. Jarvik, HA Viernes, FM Farin, T Smith-Weller, GM. Franklin, WT Longstreth Jr., PD. Swanson, and LG Costa. 2003.  Paraoxonase 1 promoter and coding region polymorphisms in Parkinson’s disease. J Neurol Neurosurg Psychiatry 74:546-547.  

B. Eskenazi, K. Harley, A. Bradman, E. Weltzien, N. Jewell, D. Barr, C. Furlong, and N. Holland.  2004.  Association of in utero Organophosphate Pesticide Exposure and Fetal Growth and Length of Gestation in an Agricultural Populations. Environ Health Perspect 112:1116-1124

RJ Richer, RL Jampsa, GP Jarvik, LG Costa and CE Furlong.  Determination of paraoxonase 1 (PON1) status and genotypes at specific polymorphic sites. Current Protocols in Toxicology, MD Mains, LG Costa, DJ Reed, E Hodgson, eds.  John Wiley and Sons, NY, NY.  2004: 4.12.1-4.12.19

Document info
Document views132
Page views133
Page last viewedFri Dec 09 19:03:37 UTC 2016
Pages49
Paragraphs315
Words5623

Comments